Navigation Links
Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy
Date:7/17/2008

- Ablative Solution to Treat Deep Wrinkles and Significant Photo Damage - Integrated Micro Ablative Scanning Technology Optimizes Patient Treatment - Newest Addition Broadens Affirm(TM) Family to Provide Industry's Most

Comprehensive Anti-Aging Solution

WESTFORD, Mass., July 17 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today launched the Affirm CO2(TM), an ablative workstation with a proprietary scanning delivery system that combines ablative CO2 skin resurfacing and rejuvenation in a single laser system.

"Affirm CO2 is a dynamic platform to address deep wrinkles, significant photoaging, severe scar damage and other difficult-to-treat skin conditions," said Cynosure President and Chief Executive Officer Michael Davin. "Our newest flagship workstation integrates a carbon dioxide laser, with Micro Ablative scanning technology and is considered the most effective treatment option for deep wrinkles. The result is a system that helps patients look years younger with minimal downtime, and affords physicians substantial flexibility in treatment options. The Affirm CO2 system offers a range of settings that enable physicians to customize the treatment based on the aesthetic goals and downtime expectations of individual patients."

The Affirm CO2 system with Micro Ablative scanning technology is the newest flagship addition to Cynosure's Affirm(TM) family of products for anti-aging indications. The original Affirm Workstation, introduced in 2006, delivers a non-ablative treatment designed to produce progressive results in patients with fine to moderate wrinkles and sun-damaged skin. By contrast
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cynosure Announces Schedule of Upcoming Investor Conferences
2. Cynosure Appoints H. Travis Lee as Vice President of Global Marketing
3. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
4. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
5. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
6. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
7. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
8. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
9. Nikon Instruments Introduces New Microscopes and Illumination Stand for Education and OEM Markets
10. Liko Introduces Two Additions to Its Stat Family of Low Friction Sheets
11. Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., Nov. 5 GenVec, Inc. (N...ts for the third quarter ended September 30, 2009.... per share) for the three months ended September 3....08 per share) in the comparable quarter of 2008. ...ec,s net loss was $14.1 million ($0.15 per share),...
(Date:11/5/2009)... Nov. 5 DSM Pharmaceutical Product... alliance with Galenix, Saint Jean D,Illac, France... manufacturing partner for Galenix commercial prod... collaborate on business development opportunities...based on the strength of Galenix in drug product d...
(Date:11/5/2009)...alif., Nov. 5 ThermoGene...innovative products for processing and storing adu...t quarter of fiscal 2010. ,, For the quarter en...ues of $5.2 million, a 15 percent increase over re... ago. The Company said the key contributors to the...
(Date:11/5/2009)... 5 Transgenomic, Inc. (O... results for the quarter ended September 30, 2009....the tables that follow. ,, Third Quarter 2009 ... or $0.01 per share for the third quarter of 2009 ... share for the third quarter of 2008. ,, Net s...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...ology Holdings, Inc. ("Holdings",or the "Company")...ology"),one of the nation,s largest cancer service...BITDA of $51.3 million, Adjusted EBITDA of $58.0 m...h flow of $74.2 million for the,quarter ended Dece...7, the,Company reported revenue of $3.0 billion, E...
...ansgenomic Inc. (OTC,Bulletin Board: TBIO) announc...ic Inc. Fourth Quarter 2007 Earnings Release ...uary 28, 2008 @ 5:00 p.m. Eastern, Where: ht... Live over the Internet -- Simply log on to t...ss the call via telephone, call 800-895-1085 or 78...
...ORD, England, February 28, Evotec AG (Frankfurt St...s first Phase II study for EVT 302 in smoking,cess... of monoamine oxidase,B (MAO-B)., This double-bli...stigate the influence of EVT 302 on craving and wi...cigarettes in 90 smokers. Smokers will,receive a s...
Other Biology Technology:US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 2US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 3US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 4US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 5US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 6US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 7US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 8US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 9US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 10US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 11US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 12US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 13US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 14US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 15US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 16US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 17US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 18US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 19US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 20US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 21US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 22US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 23US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 24US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 25US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results 26Evotec Starts Phase II in Smoking Cessation with EVT 302 2
(Date:11/3/2009)..., FL (November 4, 2009) For more than 25 years, a...ch ( Strombus gigas ) have been unsuccessfuluntil ...ding techniques to produce beaded (nucleated) and ...ve been developed by scientists from Florida Atlan...tute (HBOI). With less than two years of research ...
(Date:11/3/2009)..., FLLaser labeling of fruit and vegetables is a ne...n dioxide laser beam is used to label, or "etch" i...d for common sticker-type labels. The technology h...d vegetables and is being used in New Zealand, Aus...n approved in Asia, South Africa, Central and Sout...
(Date:11/3/2009)...m the UCLA Henry Samueli School of Engineering and...lly reconstituted in the laboratory the enzyme res...-lowering drug lovastatin. , The research, pu...tentially lead to the development of other compoun...ovastatin-synthesizing enzyme is one of the most i...
Breaking Biology News(10 mins):Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Laser etching safe alternative for labeling grapefruit 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2CureDM Awarded 2009 Diabetes Product Innovation of the Year by Frost and Sullivan 56630 1CureDM Awarded 2009 Diabetes Product Innovation of the Year by Frost and Sullivan 56630 2CureDM Awarded 2009 Diabetes Product Innovation of the Year by Frost and Sullivan 56630 3Vitro 26apos 3Bs Cancer Stem Cell Therapy Complements New Hedge Hog Drugs 56629 1Vitro 26apos 3Bs Cancer Stem Cell Therapy Complements New Hedge Hog Drugs 56629 2Vitro 26apos 3Bs Cancer Stem Cell Therapy Complements New Hedge Hog Drugs 56629 3Vitro 26apos 3Bs Cancer Stem Cell Therapy Complements New Hedge Hog Drugs 56629 4HMS Holdings Corp to Present at Investor Conferences 56627 1
...st can now detect a crippling disease called QPX o...nia and north to Canada. Although it does not affe... the disease can have a significant impact on a lo...lfish harvests and commercial aquaculture operatio...gle-celled organism related to slime mold. It was ...
...uence the genome of a microbiological master of ad...e particularly interesting for scientists because ...conditions, for instance under high salt concentra...e,s masters of adaptation, they are model organism...t the first organisms on earth. , The scientists s...
...restoring a gene often silenced in lung cancer cau... lead to a new strategy for treating the disease. ...hich is lost or silenced in a large majority of lu...rostate, bladder, esophagus and pancreas. The work...y Comprehensive Cancer Center ? Arthur G. James Ca...
Other Biology News:New genetic test can detect clam disease 2Life in deadly conditions 2Life in deadly conditions 3Restoring silenced suppressor gene kills lung-cancer cells 2
LIC Duet™ Trx•Tag™ Ek Adaptor from Novagen
Corning Culture Flask, 25 cm2, Tc-Treated, Angled Neck, Phenolic-Style Cap, Sterile from Sigma-Aldrich
Newborn Calf serum from Equitech-Bio
Corning Culture Flask, 75 cm2, Tc-Treated, Angled Neck, Plug Seal, Sterile from Sigma-Aldrich
Biology Products: